About
Partner at Third Rock Ventures who joined in 2022, previously president and CEO of Constellation Pharmaceuticals until its 2021 acquisition and chief business officer at Jounce Therapeutics through its IPO. He holds an MBA from Columbia and a biochemistry/economics degree from Rutgers, and serves on boards at Flare Therapeutics, Synnovation, and TRIANA Biomedicines.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Experience
- Third Rock VenturesPartnercurrent2022 — present
- Third Rock VenturesBoard Member - Mass Medicines, Inc.current2025 — present
- Third Rock VenturesBoard Member - Synnovation, Inc.current2024 — present
- Third Rock VenturesBoard Member - Flare Therapeutics, Inc.current2022 — present
- TRIANA BiomedicinesChair of the Board of Directorscurrent2022 — presentGreater Boston
- Jounce Therapeutics, Inc.Chair of the Board of Directors2021 — 2023Greater Boston
- Constellation Pharmaceuticals, Inc. (Acquired)Chief Executive Officer2017 — 2021Cambridge, Massachusetts
- Jounce Therapeutics, Inc.Chief Business Officer2012 — 2017Greater Boston
- Constellation PharmaceuticalsHead of Corporate Development2009 — 2013Greater Boston
- Red Abbey Venture PartnersKauffman Fellow (2005-2007), Principal (2007-2009) Venture Partner (2009)2005 — 2009Washington DC-Baltimore Area
- PfizerSummer - New Product Development - Marketing2004New York City Metropolitan Area
- BiogenMarket & Business Development1999 — 2003Cambridge, Massachuesetts
- A.T. KearneyBusiness Analyst1998 — 1999New York City Metropolitan Area
Skills & more
Biotechnology17Life Sciences12Pharmaceutical Industry8Venture Capital5Corporate Development3Business Development3Start-ups1StrategyDrug DiscoveryBusiness Strategy1BiopharmaceuticalsManagement
+2 more
Drug DevelopmentOncologyFrom Jigar's professional profile.
Investments
Board seats
Flare Therapeutics, Inc.Synnovation, Inc.Triana Biomedicines, Inc.
Per the firm's website.
Colleagues at Third Rock Ventures
Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures
Frequently asked questions
- Who is Jigar Raythatha?
- Partner at Third Rock Ventures who joined in 2022, previously president and CEO of Constellation Pharmaceuticals until its 2021 acquisition and chief business officer at Jounce Therapeutics through its IPO. He holds an MBA from Columbia and a biochemistry/economics degree from Rutgers, and serves on boards at Flare Therapeutics, Synnovation, and TRIANA Biomedicines.
- Where does Jigar Raythatha work?
- Jigar Raythatha is Partner at Third Rock Ventures.
- What does Jigar Raythatha invest in?
- Jigar Raythatha invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What boards does Jigar Raythatha sit on?
- Jigar Raythatha holds tracked board seats at Flare Therapeutics, Inc., Synnovation, Inc., Triana Biomedicines, Inc..
- Where did Jigar Raythatha go to school?
- Jigar Raythatha studied at Columbia Business School (MBA); Rutgers University (B.A., Biochemistry/Economics).
Same school
Also attended Columbia Business School668
Ryan PetersenFounder & CEO of FlexportAryo TehranianManaging Director at Mayfair Equity PartnersYibo NianInvestment Director at Intel CapitalKesha CashFounder & General Partner at Impact America FundMahati SridharPartner, Rise of the Rest at RevolutionGiuseppe IademarcoHead of Global Partnership at P101 Ventures
+ 662 more
Also attended Rutgers University120
Robin LiInvestor at GGV CapitalDominique LittleGovernment Affairs Lead at ParadigmGanesh PersadVice President & Chief Information Officer at Flare Capital PartnersMark FieldsInvestor at Alsop Louie PartnersBasil AlomaryPrincipal, Head of Research & Growth Strategy at StripesBrigitte KleineOperating Partner at Stripes
+ 114 more
Shared employers
Also worked at TRIANA Biomedicines1
Also worked at Jounce Therapeutics, Inc.2
Also worked at Pfizer152
Abbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesBriggs MorrisonEntrepreneur Partner at MPM BioImpactJohn McKearnSenior Advisor at RiverVest Venture Partners, focused on early-stage biotech
+ 146 more
Also worked at Biogen29
Richard RansohoffVenture Partner at Third Rock VenturesIsaiah Baril-DoreInvestor at Index VenturesSteve HoltzmanBio Advisor at Amplify PartnersRoy LobbVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityZach MartinsAssistant Controller at Pillar VC
+ 23 more